Ringworm: Fungal Skin Infections: Merck Manual Home Edition Section Skin Disorders Subject Fungal Skin Infections Ringworm Ringworm (tinea) is a fungal skin infection caused by several different fungi and generally classified by its location on the body.
Vaginal Infections: Merck Manual Home Edition Some Vaginal Infections Infection Symptoms Complications Treatment Bacterial vaginosis A thin, white, gray or yellowish cloudy discharge with a foul or fishy odor that may become stronger after sexual intercourse Itching and irritation Pelvic inflammatory disease Infections of the membranes around the fetus Infections of the uterus after delivery of a baby or after surgery...
Vaginal Infections: Merck Manual Home Edition Some Vaginal Infections Infection Symptoms Complications Treatment Bacterial vaginosis A thin, white, gray or yellowish cloudy discharge with a foul or fishy odor that may become stronger after sexual intercourse Itching and irritation Pelvic inflammatory disease Infections of the membranes around the fetus Infections of the uterus after delivery of a baby or after surgery...
Ringworm: Fungal Skin Infections: Merck Manual Home Edition Topical Antifungal Drugs Amorolfine Butenafine Ciclopirox Clotrimazole Econazole Haloprogin Ketoconazole Miconazole Naftifine Nystatin ( Candida only) Oxiconazole Selenium sulfide (shampoo for tinea versicolor) Sulconazole Terbinafine Terconazole Tioconazole Tolnaftate Undecylenate Last reviewed/revised February 1, 2003 Back to Top Previous: Candidiasis Next: Tinea Versicolor...
Vaginal medications for vaginal yeast infections - [Medication] - Quest Diagnostics Patient Health Library Topic Contents - Examples - How It Works - Why It Is Used - How Well It Works - Side Effects - What To Think About - References Vaginal medications for vaginal yeast infections - [Medication] - Quest Diagnostics Patient Health Library Vaginal medications for vaginal yeast infections - [Medication] - Quest Diagnostics Patient Health Library betamethasone dipropionate, Butoconazole,...
Microsoft Word - RPSepicPOM Mebendazole 1989 1989: 243: 548 Ovex , Pripsen Dextromethorphan c/ r 1989 1989: 243: 548 Hyoscine Butylbromide 1991 191: 246: 510 Buscopan Nicotine chewing gum 2mg 1991 1991: 246: 510, 552 All products now GSL 6 Vaginal imidazoles 1992 1998: 249: 38,79 Abtrim, Candiden, Daktarin, Canesten, Ecostatin, Fungederm, Gyno- Pevaryl, Hydrocortisone/ crot amiton 1992 1992: 249: 38 Eurax HC...
Microsoft Word - RPSepicPOM page 7
Cytochrome P/Related Products - - - Family view Cytochrome P/Related Products Items 10-17 of 17 Page 2 of 2 Select page: << - 1 -2- - Prod
http://www.fda.gov/cder/orange/appendix_a.txt 2, BUTABARBITAL SODIUM SARISOL, BUTABARBITAL SODIUM APPENDIX A PRODUCT NAME INDEX SATRIC, METRONIDAZOLE SCABENE, LINDANE SCANDONEST L, LEVONORDEFRIN SCANDONEST PLAIN, MEPIVACAINE HYDROCHLORIDE SCLEROSOL, TALC SCRUBTEAM SURGICAL SPONGEBRUSH, HEXACHLOROPHENE SEASONALE, ETHINYL ESTRADIOL SECOBARBITAL SODIUM, SECOBARBITAL SODIUM SECONAL SODIUM, SECOBARBITAL SODIUM SECREFLO, SECRETIN...
http://www.fda.gov/cder/dmf/text/4Q2003ACTIVETYPE2TEXT.txt "TERAZOSIN HCL-FORM 1, MANUFACTURED IN VARESE, ITALY" 12585 09-Jul-97 ACS DOBFAR SPA "SODIUM BICARBONATE, STERILE, MANUFACTURED IN MILANO, ITALY" 12586 09-Jul-97 ACS DOBFAR SPA "CEPHALOTHIN SODIUM, ORAL GRADE, MANUFACTURED IN MILANO, ITALY" 12589 11-Jul-97 ORION CORP FERMION "AZATHIOPRINE, MANUFACTURED IN OULU, FINLAND" 12596 18-Jul-97 AMCIS AG "TROPICAMIDE, MANUFACTURED IN BUDENDORF...
http://www.int-med.uiowa.edu/Intranet/Residents/xToDelete/GMedCurricOld/Jan-Jun%2004/Vaginitis/1896.pdf THERAPY FOR VAGINAL CANDIDIASIS.* DRUG FORMULAOON DOSAGE REGIMEN Butoconazole (Femstat) t Clotrirnazole (Gyne- iotrimin, Mycelex) t 5 gadayfor3 days 5 g a day for 7- 14 days 1adayfor7daysor2a day for 3 days 1 tablet 5 ga day for 7 days 1 a day for 7 days 1 a day for 3 days 1 suppository 5 gaday for 3 days 5 g in a single dose 5 g a day for 7 days 5 ga day for 3 days 1 a day for 3...
author: floerchingerd [ M68498 ]
http://www.int-med.uiowa.edu/Intranet/Residents/xToDelete/GMedCurricOld/Jan-Jun%2004/Vaginitis/1896.pdf page 4
author: floerchingerd [ M68498 ]
http://www.int-med.uiowa.edu/Intranet/Residents/xToDelete/GMedCurricOld/Jan-Jun%2004/Vaginitis/271.pdf FDA- APPROVED ANTIFUNGAL MEDICATIONS Dosage Medication How Supplied Prescription I Oral agents Fluconazole 1 tablet orally 1 time 150- mg tablet Topical agents Butoconazole 2% vaginal cream (5 g) Clotrimazole 100- mg tablet 500- mg tablet 1% vaginal cream 200- mg vaginal 6.5% ointment (4.6 g) 0.8% cream (5 g) 80- mg vaginal Miconazole Tioconazole Terconazole Nonpregnant: 1...
author: floerchingerd [ M68498 ]
http://www.int-med.uiowa.edu/Intranet/Residents/xToDelete/GMedCurricOld/Jan-Jun%2004/Vaginitis/271.pdf page 5
author: floerchingerd [ M68498 ]
First-Time Generics - November 2001 Food and Drug Administration • Center for Drug Evaluation and Research Drug Information Search First-Time Generics - November 2001 - Approval Date Drug Name Brand Name ANDA Number Applicant 11/2/01 RIMANTADINE HYDROCHLORIDE TABLETS 100 MG FLUMADINE TABLETS 75-916 COREPHARMA LLC 11/16/01 OMEPRAZOLE DELAYED-RELEASE CAPSULES 10 MG, 20 MG, AND 40 MG PRILOSEC DELAYED-RELEASE CAPSULES...
author: USERNAME
ANDA Approvals November 2001 Food and Drug Administration • Center for Drug Evaluation and Research Drug Information Search Approvals - November 2001 - - ANDA Number Drug Name Applicant Approval Date 1 75-916 RIMANTADINE HYDROCHLORIDE TABLETS 100 MG COREPHARMA LLC 11/2/01 2 75-682 IBUPROFEN TABLETS, USP 400 MG, 600 MG, AND 800 MG BASF CORPORATION 11/14/01 3 75-347 OMEPRAZOLE DELAYED-RELEASE CAPSULES 10 MG,...
author: USERNAME
FDA Drug Approvals List November 2001 - Drug Approvals for November 2001 Definitions and Notes Original New Drug Applications Original Application #: 021277 Approval Date: 30-NOV-01 Trade Name: AVELOX Chemical Type: 3 Therapeutic Potential: S Dosage Form: INJECTABLE Applicant: BAYER CORP PHARMACEUTICAL DIV Active Ingredient(s): MOXIFLOXACIN HYDROCHLORIDE OTC/RX Status: RX Indication(s): For the treatment of adults ...
FDA Drug Approvals List August 2001 JOHNSON PHARMACEUTICAL RESEARCH INSTITUTE Active Ingredient(s): COPPER OTC/RX Status: RX Application #:018612 Labeling Supplement#: 026 To Original New Drug Application Approval Date: 24-AUG-01 Trade Name: NICORETTE Dosage Form: GUM, CHEWING Applicant: SMITHKLINE BEECHAM CONSUMER HEALTHCARE LP Active Ingredient(s): NICOTINE POLACRILEX OTC/RX Status: RX Application #: 014879 Labeling...
FDA Drug Approvals List April 2001 - Drug Approvals for April 2001 Definitions and Notes Original New Drug Applications Original Application #: 020949 Approval Date: 30-APR-01 Trade Name: ACCUNEB Chemical Type: 5 Therapeutic Potential: S Dosage Form: SOLUTION Applicant: DEY LABORATORIES INC Active Ingredient(s): ALBUTEROL SULFATE OTC/RX Status: RX Indication(s): For the treatment of asthma-related bronchospasm in...
Prescription and OTC Drug Product List 11/2001 IRRIGANT -D- MONARCH PHARMS EQ 40MG BASE/ML;200,000 UNITS/ML N60707 001 JUN 28, 1966 NOV CRLD -A- + EQ 40MG BASE/ML;200,000 UNITS/ML N60707 001 JUN 28, 1966 NOV CRLD OMEPRAZOLE CAPSULE, DELAYED REL PELLETS; ORAL -A- OMEPRAZOLE -A- AB ANDRX PHARMS 10MG N75347 001 NOV 16, 2001 NOV NEWA -A- AB 20MG N75347 002 NOV 16, 2001 NOV NEWA -A- AB 40MG N75347 003 NOV 16, 2001 NOV NEWA -A-...
SSCI Inc.: X-ray Powder Diffraction, Raman and Infrared Spectroscopy, Differential Scanning Calorimetry, and Thermogravimetric Phone: 800 375-2179 / 765 463-0112 Fax: 765 497-2649 / 765 463-4722 E-mail: info@ssci-inc.com SSCI Inc., 3065 Kent Avenue, West Lafayette, IN 47906 - 1076 USA Acetaminophen Acetazolamide Acetohexamide Acetylcysteine Acyclovir Adenine L-Alanine Albuterol Albuterol Sulfate Allopurinol Alprazolam Amantadine HCl Amiloride HCl Aminobenzoic Acid Aminoglutethimide Aminosalicylic Acid...
author: SSCI Webmaster
Medicines, Ethics and Practice page 8
http://www.fda.gov/cder/foi/appletter/2001/20676s4ltr.pdf NDA 20- 676/ S- 004 Bristol- Myers Squibb Company Attention: MrTioconazole Ointment 6.5% Vaginal Antifungal)
http://www.fda.gov/cder/foi/appletter/2001/20676s4ltr.pdf page 1
http://www.fda.gov/cder/foi/appletter/2001/20676s3ltr.pdf NDA 20- 676/ S- 001 NDA 20- 676/ S- 003 Bristol Myers Squibb 24 APR 2001 Attention: Mr
